Advances in the Diagnosis and Treatment of Barrett’s Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium

Jon C. Gould, Mark R. Wendling, Brant K. Oeschlager, Sumeet K. Mittal, Srinadh Komanduri, Kyle A. Perry, Sean Cleary, Susan Galandiuk, Daniel J. Scott, P. Marco Fisichella, Nicholas J. Shaheen, Kelly R. Haisley, John G. Hunter

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Patients with Barrett’s esophagus (BE) are at increased risk of developing esophageal adenocarcinoma (EAC). The incidence of EAC is rising faster than any other cancer. Discussion: Patients with BE have a 30- to 40-fold increased risk of EAC. In the past 20 years, there have been dramatic advances in our understanding of the incidence and natural history of BE. Endoscopic treatment of BE is evolving. Even early EAC has been treated without esophagectomy and good oncologic results in the modern era.

Original languageEnglish (US)
Pages (from-to)1342-1349
Number of pages8
JournalJournal of Gastrointestinal Surgery
Volume21
Issue number8
DOIs
StatePublished - Aug 1 2017

Keywords

  • Barrett’s esophagus
  • Early esophageal adenocarcinoma

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Advances in the Diagnosis and Treatment of Barrett’s Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium'. Together they form a unique fingerprint.

Cite this